%@LANGUAGE="VBSCRIPT" CODEPAGE="936"%>
|
||||||||||||||||||||||||||||||||||||||||||||
![]() |
||||||||||||||||||||||||||||||||||||||||||||
Brief introduction of Sinphar Group People nowadays pay more attention to health care, new medicine research and quality control is the key to success for pharmaceutical industry. Sinphar Tian-li pharmaceutical co., Ltd., holding the idea "Public health is the target of Sinphar ", keeps on exploring and producing new high quality medicines. Its good management concept and team-working spirit won its positive position in the competition. Guided by the principle "treating people honestly and dealing with business patiently", the company sale grows continuously and stably during the past more than 20 years. The scale of Sinphar is expanding. In 1997 Sinphar established a subcompany, CanCap Pharmaceutical, in Canada. In 2002, Siphar purchased Hangzhou Tian-li pharmaceutical and renamed it Sinphar Tian-li Pharmaceutical Co., Ltd. (Hangzhou). In the same year, Sinphar set up a R&D centre in Taiwan. These four organizations constitute a group-managed entity, the Sinphar pharmaceutical group. Now Sinphar is becoming an international enterprise. |
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
Brief introduction of Sinphar Tian-li Sinphar Tian-li Pharmaceutical Co., Ltd. (Hangzhou). is a subcompany of Sinphar pharmaceutical group, which is a listed company in Taiwan stock market. The founding of Sinphar Tian-li means Sinphar made another important step on the way to internationalization following the investment in CanCap, Canada and the R&D center, Taiwan. |
||||||||||||||||||||||||||||||||||||||||||||
Sinphar Tian-li Pharmaceutical Co. Ltd (Hangzhou) has built a strategic partnership with Shanghai Life Science Institute, which belongs to Chinese |
||||||||||||||||||||||||||||||||||||||||||||
Science Academy, and Chinese Traditional Medicine Modern Research Centre, Beijing University. Sinphar Tian-li owns a professional researching team and advanced facilities for new product R&D. Sinphar Tian-li achieved 48 medicine manufacture certificates. Most of these products such as "Tian-li Ìå±£®¡¢Capsule ÐÄÄÔ½¡¡¢Tian-liÈóÖéeye-drop¡¡"have been put into market for long time and won great reputation in clinic doctors and consumers. Sinphar Tian-li owns 6 factories. They are: pharmaceutical factory, health food factory, cosmetic factory, extracting factory, disinfectant factory, and raw material processing factory. Sinphar Tian-li has a certified QC system and a broad sales network which covers the East China, North China, South China, and Southwest China areas. With the support of global resources from its parent company, Sinphar Tian-li is stepping onto the international market stably. |
||||||||||||||||||||||||||||||||||||||||||||
![]() |
||||||||||||||||||||||||||||||||||||||||||||